Sj?gren's Versus Non-Sj?gren's Ocular Features: Similar Symptoms, But Significantly Worse Signs

PURPOSE. To examine the ocular signs and symptoms in participants of the Sjogren's International Collaborative Clinical Alliance cohort, and to compare them across Sjogren's disease (SjD) status. METHODS. Our study population comprised 3380 Sjogren's International Collaborative Clinical Alliance participants who had no missing data relevant to this study. Participants' SjD status was assessed using the updated 2016 American College of Rheumatism/European League Against Rheumatism SjD classification criteria. Participants completed baseline questionnaires of ocular symptoms and underwent ocular examinations. Differences in the ocular signs and symptoms between SjD and non-SjD groups were assessed. We used multivariable linear and linear mixed -effects models to investigate the impact of SjD on Ocular Surface Disease Index -6 and OSS. RESULTS. Among 1532 participants classified as SjD, their Ocular Surface Disease Index -6 did not clinically differ from those classified as non-SjD (adjusted difference, -0.97; 95% confidence interval, -1.52 to -0.41). However, SjD participants exhibited an elevated ocular staining score (adjusted difference, 3.47; 95% confidence interval, 3.36-3.57; P < 0.001) compared with non-SjD participants. In addition, SjD was associated with increased odds of ocular signs, such as reduced tear break-up time, abnormal Schirmer I test, and corneal abnormalities, and was strongly related to more intense corneal and conjunctival staining, as well as additional corneal staining points. CONCLUSIONS. SjD is associated with a higher risk of ocular signs and pathology compared with non-SjD, whereas ocular symptoms remain similar. In addition, corneal abnormalities and corneal staining patterns could serve as a potential biomarker in identifying SjD-related dry eye.